Guarantor Infromation (Cash Flows) (Details) - USD ($) $ in Thousands	2 Months Ended	7 Months Ended	9 Months Ended
	Sep. 30, 2015	Aug. 14, 2015	Sep. 30, 2014
Cash flow from financing activities:
Cash and cash equivalents at beginning of period		$ 17,550
Cash and cash equivalents at end of period	$ 13,461
Parent Company [Member]
Cash flow from financing activities:
Cash and cash equivalents at beginning of period		0
Cash and cash equivalents at end of period	0
Guarantor Subsidiaries [Member]
Cash flow from financing activities:
Cash and cash equivalents at beginning of period		5,503
Cash and cash equivalents at end of period	155
Non-Guarantor Subsidiaries [Member]
Cash flow from financing activities:
Cash and cash equivalents at beginning of period		12,047
Cash and cash equivalents at end of period	13,306
Consolidating Entries and Eliminations [Member]
Cash flow from financing activities:
Cash and cash equivalents at beginning of period		0
Cash and cash equivalents at end of period	0
Predecessor
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities		28,323	$ 82,889
Cash flow from investing activities:
(Loans to) repayments from affiliates		0	0
Capital expenditures		(32,301)	(69,314)
Proceeds from Sale of Productive Assets		646	4,079
Proceeds from derivative instruments		(8,263)	(573)
Insurance recoveries		0	2,834
Net cash used in investing activities		(39,918)	(62,974)
Cash flow from financing activities:
Repayments to affiliates		0
Loans from (repayments to) affiliates			0
Short-term debt borrowings		18,511	(17)
Revolving Facility borrowings		160,000	229,000
Revolving Facility reductions		(99,000)	(240,000)
Repayment of Senior Subordinated Notes		(200,000)	0
Issuance of Preferred Shares		150,000	0
Principal payments on long term debt		(89)	(158)
Supply chain financing		0	(9,455)
Proceeds from exercise of stock options		32	2,813
Purchase of treasury shares		(63)	(620)
Revolving Facility refinancing		(5,068)	(2,741)
Other		(3,499)	1,011
Net cash (used in) provided by financing activities		20,824	(20,167)
Net increase (decrease) in cash and cash equivalents		9,229	(252)
Effect of exchange rate changes on cash and cash equivalents		(1,746)	(758)
Cash and cash equivalents at beginning of period	25,033	17,550	11,888
Cash and cash equivalents at end of period		25,033	10,878
Predecessor | Parent Company [Member]
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities		(4,017)	(10,274)
Cash flow from investing activities:
(Loans to) repayments from affiliates		36,204	7,070
Capital expenditures		0	0
Proceeds from Sale of Productive Assets		0
Proceeds from derivative instruments		0	0
Insurance recoveries		0	0
Net cash used in investing activities		36,204	7,070
Cash flow from financing activities:
Repayments to affiliates		21,343
Loans from (repayments to) affiliates		0	0
Short-term debt borrowings		0	0
Revolving Facility borrowings		0	0
Revolving Facility reductions		0	0
Repayment of Senior Subordinated Notes		(200,000)
Issuance of Preferred Shares		150,000
Principal payments on long term debt		0	0
Supply chain financing		0	0
Proceeds from exercise of stock options		32	2,813
Purchase of treasury shares		(63)	(620)
Revolving Facility refinancing		0	0
Other		(3,499)	1,011
Net cash (used in) provided by financing activities		(32,187)	3,204
Net increase (decrease) in cash and cash equivalents		0	0
Effect of exchange rate changes on cash and cash equivalents		0	0
Cash and cash equivalents at beginning of period	0	0	0
Cash and cash equivalents at end of period		0	0
Predecessor | Guarantor Subsidiaries [Member]
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities		34,418	50,298
Cash flow from investing activities:
(Loans to) repayments from affiliates		(21,343)	0
Capital expenditures		(20,572)	(49,756)
Proceeds from Sale of Productive Assets		397	1,706
Proceeds from derivative instruments		(7,595)	(51)
Insurance recoveries		0	0
Net cash used in investing activities		(49,113)	(48,101)
Cash flow from financing activities:
Repayments to affiliates		(36,204)
Loans from (repayments to) affiliates		0	(7,070)
Short-term debt borrowings		14,002	965
Revolving Facility borrowings		126,000	151,000
Revolving Facility reductions		(87,000)	(148,000)
Repayment of Senior Subordinated Notes		0
Issuance of Preferred Shares		0
Principal payments on long term debt		(89)	(98)
Supply chain financing		0	0
Proceeds from exercise of stock options		0	0
Purchase of treasury shares		0	0
Revolving Facility refinancing		(5,037)	(2,384)
Other		0	0
Net cash (used in) provided by financing activities		11,672	(5,587)
Net increase (decrease) in cash and cash equivalents		(3,023)	(3,390)
Effect of exchange rate changes on cash and cash equivalents		0	0
Cash and cash equivalents at beginning of period	2,480	5,503	4,752
Cash and cash equivalents at end of period		2,480	1,362
Predecessor | Non-Guarantor Subsidiaries [Member]
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities		25,632	42,865
Cash flow from investing activities:
(Loans to) repayments from affiliates		0	0
Capital expenditures		(11,729)	(19,558)
Proceeds from Sale of Productive Assets		249	2,373
Proceeds from derivative instruments		(668)	(522)
Insurance recoveries		0	2,834
Net cash used in investing activities		(12,148)	(14,873)
Cash flow from financing activities:
Repayments to affiliates		0
Loans from (repayments to) affiliates		(27,710)	0
Short-term debt borrowings		4,509	(982)
Revolving Facility borrowings		34,000	78,000
Revolving Facility reductions		(12,000)	(92,000)
Repayment of Senior Subordinated Notes		0
Issuance of Preferred Shares		0
Principal payments on long term debt		0	(60)
Supply chain financing		0	(9,455)
Proceeds from exercise of stock options		0	0
Purchase of treasury shares		0	0
Revolving Facility refinancing		(31)	(357)
Other		0	0
Net cash (used in) provided by financing activities		(1,232)	(24,854)
Net increase (decrease) in cash and cash equivalents		12,252	3,138
Effect of exchange rate changes on cash and cash equivalents		(1,746)	(758)
Cash and cash equivalents at beginning of period	22,553	12,047	7,136
Cash and cash equivalents at end of period		22,553	9,516
Predecessor | Consolidating Entries and Eliminations [Member]
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities		(27,710)	0
Cash flow from investing activities:
(Loans to) repayments from affiliates		(14,861)	(7,070)
Capital expenditures		0	0
Proceeds from Sale of Productive Assets		0
Proceeds from derivative instruments		0	0
Insurance recoveries		0	0
Net cash used in investing activities		(14,861)	(7,070)
Cash flow from financing activities:
Repayments to affiliates		14,861
Loans from (repayments to) affiliates		27,710	7,070
Short-term debt borrowings		0	0
Revolving Facility borrowings		0	0
Revolving Facility reductions		0	0
Repayment of Senior Subordinated Notes		0
Issuance of Preferred Shares		0
Principal payments on long term debt		0	0
Supply chain financing		0	0
Proceeds from exercise of stock options		0	0
Purchase of treasury shares		0	0
Revolving Facility refinancing		0	0
Other		0	0
Net cash (used in) provided by financing activities		42,571	7,070
Net increase (decrease) in cash and cash equivalents		0	0
Effect of exchange rate changes on cash and cash equivalents		0	0
Cash and cash equivalents at beginning of period	$ 0	0	0
Cash and cash equivalents at end of period		$ 0	$ 0